Evidence map›Paper›PMID 26632769›Full record

ReviewCurrent opinion in oncology2016

Single-cell approaches for molecular classification of endocrine tumors.

James Koh, Nancy L Allbritton, Julie A Sosa

Abstract readReview
In one paragraph

Review in Current opinion in oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James KohaDepartment of Surgery, Duke University Medical Center, Durham bDepartment of Biomedical Engineering, University of North Carolina and N.C. State University, Raleigh cDepartments of Surgery and Medicine, Duke Cancer Institute and Duke Clinical Research Institute, Durham, North Carolina, USA.
Nancy L Allbritton
Julie A Sosa

Funding

Single-Cell Measurement of Lipid Signaling in Colorectal CancerR01CA177993 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2014 to 2018
$3.0M
Molecular Mechanisms of Altered Calcium Sensing in Human Parathyroid DiseaseR01DK088188 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI KOH, JAMES, OLSON, JOHN A. · 2010 to 2014
$1.7M
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasiaR21CA192004 · NCI · DUKE UNIVERSITY · PI KOH, JAMES, SOSA, JULIE ANN · 2015 to 2016
$414k
NCI NIH HHS 1R21CA192004-01NCI NIH HHS R01 CA177993NCI NIH HHS R01CA177993NCI NIH HHS R21 CA192004NIDDK NIH HHS 5R01DK088188-05NIDDK NIH HHS R01 DK088188
6 · The paper itself

Abstract

purpose of reviewIn this review, we summarize recent developments in single-cell technologies that can be employed for the functional and molecular classification of endocrine cells in normal and neoplastic tissue. RECENT

findingsThe emergence of new platforms for the isolation, analysis, and dynamic assessment of individual cell identity and reactive behavior enables experimental deconstruction of intratumoral heterogeneity and other contexts where variability in cell signaling and biochemical responsiveness inform biological function and clinical presentation. These tools are particularly appropriate for examining and classifying endocrine neoplasias, as the clinical sequelae of these tumors are often driven by disrupted hormonal responsiveness secondary to compromised cell signaling. Single-cell methods allow for multidimensional experimental designs incorporating both spatial and temporal parameters with the capacity to probe dynamic cell signaling behaviors and kinetic response patterns dependent upon sequential agonist challenge. SUMMARY: Intratumoral heterogeneity in the provenance, composition, and biological activity of different forms of endocrine neoplasia presents a significant challenge for prognostic assessment. Single-cell technologies provide an array of powerful new approaches uniquely well suited for dissecting complex endocrine tumors. Studies examining the relationship between clinical behavior and tumor compositional variations in cellular activity are now possible, providing new opportunities to deconstruct the underlying mechanisms of endocrine neoplasia.

Indexed as

Cell SeparationEndocrine Gland NeoplasmsHumansLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesNeoplastic Cells, CirculatingSignal TransductionSingle-Cell AnalysisThyroid Carcinoma, AnaplasticThyroid Neoplasms

Identifiers

PMID26632769
PMCPMC4669879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.